16 related articles for article (PubMed ID: 28598077)
1. Expression of CD4
Song X; Yang Y; Cui J; Sun J; Zhang J; Gao L; Liu J
Tohoku J Exp Med; 2024 May; ():. PubMed ID: 38797702
[No Abstract] [Full Text] [Related]
2. Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms.
Baumeister J; Chatain N; Hubrich A; Maié T; Costa IG; Denecke B; Han L; Küstermann C; Sontag S; Seré K; Strathmann K; Zenke M; Schuppert A; Brümmendorf TH; Kranc KR; Koschmieder S; Gezer D
Leukemia; 2020 Apr; 34(4):1062-1074. PubMed ID: 31728053
[TBL] [Abstract][Full Text] [Related]
3. [Anti-angiogenic effect of interferon on JAK2V617F positive myeloproliferative neoplasms and its anti-angiogenic mechanisms].
Fu J; Xu Q; Zhao Y; Liu G; Cheng Z; Liang W; Xie X; Gu L
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(46):3727-32. PubMed ID: 26850010
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells.
Cheng Z; Fu J; Liu G; Zhang L; Xu Q; Wang SY
Leuk Lymphoma; 2018 Jan; 59(1):196-203. PubMed ID: 28554272
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloroliferative neoplasms cells].
Liu GM; Zhang LJ; Fu JZ; Liang WT; Cheng ZY; Bai P; Bian YS; Wan JS
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):140-145. PubMed ID: 28279039
[No Abstract] [Full Text] [Related]
6. VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms.
Subotički T; Mitrović Ajtić O; Živković E; Diklić M; Đikić D; Tošić M; Beleslin-Čokić B; Dragojević T; Gotić M; Santibanez JF; Čokić V
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206393
[TBL] [Abstract][Full Text] [Related]
7. [Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines].
Wang F; Chen BA; Cheng J; Xu WL; Wang XM; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Zhang W; Xia GH; Pei XP; Wu WW; Yin L; Shan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):74-8. PubMed ID: 20137122
[TBL] [Abstract][Full Text] [Related]
8. [The Effect of Ruxolitinib on the Expression of VEGF and HIF-1α in Leukemia HEL Cells].
Xu Q; Liu GM; Wang FY; Zhang LJ; Liang WT; Cheng ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):669-673. PubMed ID: 28598077
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
